Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Juan F Burgueño
Journal Article
EDITOR'S CHOICE
Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
Inflammatory Bowel Diseases, Volume 28, Issue 12, December 2022, Pages 1800–1812, https://doi.org/10.1093/ibd/izac151
Published: 22 August 2022
Journal Article
Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis
Inflammatory Bowel Diseases, Volume 26, Issue 10, October 2020, Page e127, https://doi.org/10.1093/ibd/izaa172
Published: 03 July 2020
Journal Article
EDITOR'S CHOICE
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
Inflammatory Bowel Diseases, Volume 26, Issue 6, June 2020, Pages 797–808, https://doi.org/10.1093/ibd/izaa085
Published: 25 April 2020
Journal Article
P122 EPITHELIAL TLR4 PROMOTES OXIDATIVE STRESS VIA NADPH OXIDASE ACTIVATION AND INDUCES REDOX-SENSITIVE PATHWAYS DURING TUMORIGENESIS Get access
Inflammatory Bowel Diseases, Volume 25, Issue Supplement_1, February 2019, Page S60, https://doi.org/10.1093/ibd/izy393.138
Published: 07 February 2019
Journal Article
P142 CONSTITUTIVELY ACTIVE MAC-1 (CD11B) AMELIORATES INFLAMMATION IN MOUSE DSS COLITIS MODEL Get access
Inflammatory Bowel Diseases, Volume 25, Issue Supplement_1, February 2019, Pages S65–S66, https://doi.org/10.1093/ibd/izy393.159
Published: 07 February 2019
Journal Article
P125 TLR4 ACTIVATION UPREGULATES EXPRESSION OF OXIDATIVE ENZYMES: IMPLICATIONS FOR INTESTINAL TUMORIGENESIS AND LUMINAL MICROBIOTA Get access
Inflammatory Bowel Diseases, Volume 24, Issue suppl_1, February 2018, Page S44, https://doi.org/10.1093/ibd/izy019.137
Published: 18 January 2018
